Stay updated on Ravulizumab Study in LN/IgAN Clinical Trial

Sign up to get notified when there's something new on the Ravulizumab Study in LN/IgAN Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ravulizumab Study in LN/IgAN Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page’s displayed site/version label was updated from “Revision: v3.5.2” to “Revision: v3.5.3,” reflecting a minor platform update rather than a change to the clinical trial record.
    Difference
    0.0%
    Check dated 2026-04-24T05:50:20.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T02:13:12.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    39 days ago
    Change Detected
    Summary
    The page now reflects revision label v3.5.0 and the previous label v3.4.3 has been removed.
    Difference
    0.0%
    Check dated 2026-03-19T04:30:36.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    The page revision was updated to v3.4.3, replacing the previous v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-11T20:11:09.000Z thumbnail image
  6. Check
    75 days ago
    Change Detected
    Summary
    Revision updated to v3.4.2; the lapse-in-government funding notice and the prior revision reference (v3.4.1) were removed.
    Difference
    0.3%
    Check dated 2026-02-11T04:46:17.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    Added a government funding notice about site status and that the NIH Clinical Center is open; updated Revision: v3.4.1 and removed Revision: v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-04T03:30:11.000Z thumbnail image

Stay in the know with updates to Ravulizumab Study in LN/IgAN Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ravulizumab Study in LN/IgAN Clinical Trial page.